Last Updated on June 27, 2021 by The Health Master
Zydus Cadila has received tentative approval from the USFDA to market Pemetrexed for Injection in the strengths of 100mg/vial, 500 mg/vial, and 1000 mg/vial, single-dose vials (US RLD: Alimta), the company said in a statement.
The statement added that Pemetrexed is used to treat certain types of cancers such as lung cancer and mesothelioma. It is a chemotherapy drug that works by slowing or stopping the growth of cancer cells.
“The drug will be manufactured at the formulation manufacturing facility at Zydus Hospira, Ahmedabad.
The group now has 319 approvals and has, so far, filed over 400 ANDAs since the commencement of the filing process in FY 2003-04,” notified the statement.
Cipla gets USFDA nod for Inhalation product
Zydus Cadila gets tentative nod from USFDA for Fingolimod Capsules
Alkem gets two observations from USFDA for USA plant
Lupin gets USFDA nod for treatment of Kidney patient
Aleor gets USFDA nod for Testosterone Topical Solution
Avenue Therapeutics gets complete response letter from USFDA for IV Tramadol
Copyright – An article (Part-1)
DCGI allows to conduct phase-III clinical trials on C-19 drug
Mankind, BDR Pharma to distribute Baricitinib in India
Dr. Reddy’s Labs launches Icosapent Ethyl Capsules
IPC to sensitize stakeholders on manufacturing of Quality Drugs
Mankind launches drug to treat Diabetes, Heart failure
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
